These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35684566)

  • 1. Antimicrobial Activity of Dihydroisocoumarin Isolated from Wadi Lajab Sediment-Derived Fungus
    Orfali R; Perveen S; AlAjmI MF; Ghaffar S; Rehman MT; AlanzI AR; Gamea SB; Essa Khwayri M
    Molecules; 2022 Jun; 27(11):. PubMed ID: 35684566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial metabolites from the beetle-associated fungus Penicillium chrysogenum.
    Li TX; Su HY; Yu JC; Hao H; Jia XW; Shi FC; Xu CP
    An Acad Bras Cienc; 2023; 95(suppl 1):e20220178. PubMed ID: 37466533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
    Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
    Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial metabolites from the Indonesian mangrove sediment-derived fungus
    Newaz AW; Yong K; Yi W; Wu B; Zhang Z
    Nat Prod Res; 2023 May; 37(10):1702-1708. PubMed ID: 35879837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-(Sulfamoylbenzoyl)-L-proline Derivatives as Potential Non-β-lactam ESBL Inhibitors: Structure-Based Lead Identification, Medicinal Chemistry and Synergistic Antibacterial Activities.
    Liu X; Dong S; Ma Y; Xu H; Zhao H; Gao Q
    Med Chem; 2019; 15(2):196-206. PubMed ID: 30112996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D).
    Romero E; Oueslati S; Benchekroun M; D'Hollander ACA; Ventre S; Vijayakumar K; Minard C; Exilie C; Tlili L; Retailleau P; Zavala A; Elisée E; Selwa E; Nguyen LA; Pruvost A; Naas T; Iorga BI; Dodd RH; Cariou K
    Eur J Med Chem; 2021 Jul; 219():113418. PubMed ID: 33862516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioassay Guided Isolation and Docking Studies of a Potential β-Lactamase Inhibitor from
    Elfaky MA; El-Halawany AM; Koshak AE; Alshali KZ; El-Araby ME; Khayat MT; Abdallah HM
    Molecules; 2020 May; 25(11):. PubMed ID: 32486455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates.
    Yenn TW; Arslan Khan M; Amiera Syuhada N; Chean Ring L; Ibrahim D; Tan WN
    Steroids; 2017 Dec; 128():68-71. PubMed ID: 29104098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Spectrum of Thiazolidinediones against Respiratory Tract Pathogenic Bacteria: An In Vitro and In Silico Approach.
    Al Bratty M; Hakami AQ; Masmali HA; Alam MS; Alhazmi HA; Thangavel N; Najmi A; Moni SS; Haque A
    Curr Pharm Biotechnol; 2020; 21(14):1457-1469. PubMed ID: 32552647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,1'-Carbonyldiimidazole (CDI) Mediated Facile Synthesis, Structural Characterization, Antimicrobial Activity, and in-silico Studies of Coumarin- 3-carboxamide Derivatives.
    Salar U; Khan KM; Fakhri MI; Hussain S; Tauseef S; Ameer S; Wadood A; Khan H; Perveen S
    Med Chem; 2018; 14(1):86-101. PubMed ID: 28641525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibacterial activity of sulopenem, a new parenteral penem antibiotic].
    Inoue E; Komoto E; Taniyama Y; Mitsuhashi S
    Jpn J Antibiot; 1996 Apr; 49(4):338-51. PubMed ID: 8786625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'.
    Morinaka A; Tsutsumi Y; Yamada M; Suzuki K; Watanabe T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Mitsuhashi N; Ida T; Livermore DM
    J Antimicrob Chemother; 2015 Oct; 70(10):2779-86. PubMed ID: 26089439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, In Vitro and In Silico Studies of Indolequinone Derivatives against Clinically Relevant Bacterial Pathogens.
    Leite TOC; Novais JS; de Carvalho BLC; Ferreira VF; Miceli LA; Fraga L; Abrahim-Vieira B; Rodrigues CR; Sá Figueiredo AM; Castro HC; Cunha AC
    Curr Top Med Chem; 2020; 20(3):192-208. PubMed ID: 31868148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M; Browne FA; Jacobs MR; Appelbaum PC
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Escherichia coli and associated β-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 β-lactamases with clindamycin and piperacillin-tazobactam.
    Shahi SK; Singh VK; Kumar A
    PLoS One; 2013; 8(7):e68234. PubMed ID: 23861873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases.
    Sader HS; Rhomberg PR; Flamm RK; Jones RN; Castanheira M
    J Antimicrob Chemother; 2017 Jun; 72(6):1696-1703. PubMed ID: 28333332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of structural properties of beta-lactam antibiotics to antibacterial activity.
    Neu HC
    Am J Med; 1985 Aug; 79(2A):2-13. PubMed ID: 3895915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing of inhibitors against CTX-M-15 type β-lactamase: potential drug candidate against β-lactamases-producing multi-drug-resistant bacteria.
    Ali A; Danishuddin ; Maryam L; Srivastava G; Sharma A; Khan AU
    J Biomol Struct Dyn; 2018 May; 36(7):1806-1821. PubMed ID: 28545327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.
    Faheem M; Rehman MT; Danishuddin M; Khan AU
    PLoS One; 2013; 8(2):e56926. PubMed ID: 23437273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gram-negative organisms.
    Jamieson CE; Lambert PA; Simpson IN
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2615-8. PubMed ID: 12878527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.